Biolargo BLGO

BioLargo, Inc. is a corporation organized under the laws of the state of Delaware. The company develops and commercializes proprietary technologies focused on environmental remediation, water treatment, and medical applications. Its core activities involve creating solutions that control odor and volatile organic compounds, treat water contaminated with per- and polyfluoroalkyl substances (PFAS), and advance battery and medical device technologies. BioLargo operates through a network of wholly and partially owned subsidiaries to support research, development, manufacturing, and distribution across its technology platforms.

BioLargo generates revenue primarily through the sale of its odor and volatile organic compound control products, water treatment systems, and engineering services. The company also earns income from licensing its intellectual property and providing professional engineering and scientific consulting services. Its customer base includes municipal water treatment facilities, industrial clients, healthcare providers, and environmental remediation firms. Revenue is derived from both product sales and service contracts tied to the deployment and maintenance of its proprietary technologies.

The company operates through the following segments: BioLargo Life Technologies, ONM Environmental, BioLargo Energy Technologies, BioLargo Canada, BioLargo Engineering Science & Technologies, BioLargo Equipment Solutions & Technologies, BioLargo Development Corp., and Clyra Medical Technologies. These segments represent distinct operational divisions focused on specific technology applications and commercialization efforts.

• BioLargo Life Technologies: This segment holds the company's intellectual property and oversees the development and licensing of its core technologies. It is responsible for advancing the scientific foundation of BioLargo’s innovations across environmental and medical applications. The segment manages patent portfolios and supports technology transfer to other subsidiaries for commercialization.
• ONM Environmental: This segment manufactures, markets, sells, and distributes the company's odor and volatile organic compound control products. It commercializes the CupriDyne technology, which is used to neutralize malodors and harmful VOCs in waste handling, composting, and industrial settings. ONM Environmental operates under the brand names CupriDyne and ONM Environmental, with products deployed in municipal and industrial facilities.
• BioLargo Energy Technologies: This segment was formed to commercialize the company's proprietary battery technology. It focuses on developing advanced energy storage solutions using BioLargo’s innovative electrochemical approaches. The segment aims to bring high-performance, sustainable battery systems to market for industrial and renewable energy applications.
• BioLargo Canada: This segment serves as the primary research and development team operating in Edmonton, Alberta, Canada. It conducts scientific research and technological innovation supporting the company’s environmental and medical technology platforms. The team works on advancing core technologies related to water treatment, odor control, and antimicrobial applications.
• BioLargo Engineering Science & Technologies: This segment is a professional engineering services division located in Oak Ridge, Tennessee. It provides engineering design, testing, and validation services for water treatment and environmental remediation projects. The segment supports clients with technical expertise in PFAS remediation, system design, and compliance testing under the BLEST brand.
• BioLargo Equipment Solutions & Technologies: This segment sells the company's water treatment products, including systems designed for PFAS destruction and removal. It commercializes technologies such as the Advanced Oxidation System and other water purification equipment. The segment serves municipal and industrial customers seeking compliant water treatment solutions under the BioLargo Equipment brand.
• BioLargo Development Corp.: This segment employs and provides benefits to the company's workforce. It manages human resources, payroll, and employee benefits across BioLargo’s subsidiaries. The segment ensures operational support for personnel located in California, Tennessee, Florida, and Canada.
• Clyra Medical Technologies: This segment commercializes BioLargo’s technologies in the medical and dental fields. It focuses on developing and marketing antimicrobial and wound care products based on the company’s iodine-based platform. Clyra Medical operates under the Clyra Medical brand, with products targeting infection control in healthcare settings.

BioLargo holds a niche position in the environmental technology and medical device industries, competing with larger established firms in water treatment and infection control. Its competitive advantages stem from its proprietary iodine-based and electrochemical technologies, which offer unique performance in odor control, PFAS destruction, and antimicrobial applications. The company differentiates itself through innovation in sustainable solutions that address emerging regulatory challenges in water safety and public health.

BioLargo serves a diverse customer base including municipal water utilities, industrial manufacturers, healthcare institutions, and environmental remediation contractors. Specific customer names are not disclosed in the filing, but the company indicates its products are used in wastewater treatment facilities, composting operations, hospitals, and dental clinics. The company’s technologies are deployed across North America to address odor control, water purification, and infection prevention needs.